Hammer Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $436K | Sell |
7,036
-221
| -3% | -$13.7K | 2.11% | 27 |
|
|
2020
Q3 | $438K | Sell |
7,257
-4,290
| -37% | -$259K | 1.95% | 30 |
|
|
2020
Q2 | $679K | Sell |
11,547
-813
| -7% | -$47.8K | 1.94% | 28 |
|
|
2020
Q1 | $689K | Sell |
12,360
-28,798
| -70% | -$1.61M | 2.17% | 19 |
|
|
2019
Q4 | $2.64M | Buy |
41,158
+7
| +0% | +$449 | 1.99% | 24 |
|
|
2019
Q3 | $2.09M | Buy |
41,151
+444
| +1% | +$22.5K | 1.66% | 31 |
|
|
2019
Q2 | $1.85M | Buy |
40,707
+9
| +0% | +$408 | 1.52% | 37 |
|
|
2019
Q1 | $1.94M | Buy |
40,698
+3,525
| +9% | +$168K | 1.72% | 28 |
|
|
2018
Q4 | $1.93M | Sell |
37,173
-6,271
| -14% | -$326K | 1.89% | 22 |
|
|
2018
Q3 | $2.7M | Sell |
43,444
-183
| -0.4% | -$11.4K | 2.21% | 23 |
|
|
2018
Q2 | $2.41M | Buy |
+43,627
| New | +$2.41M | 2.11% | 25 |
|